Major update for anyone taking Atorvastatin after huge trial

All you need to know as a study found that atorvastatin reduced major cardiovascular event risk by 30% however, it did not significantly improve disability-free survival

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.mirror.co.uk)